by Comanche County Memorial Hospital | Oct 24, 2023 | Cancer Care, CCMH Community, Men's Health, Women's Health
Breast cancer is one of the most common forms of cancer worldwide, affecting millions of women and, in some cases, men. The good news is that, thanks to advancements in medical science and early detection methods, there are numerous effective treatment options...
by Comanche County Memorial Hospital | Oct 16, 2023 | Cancer Care, CCMH Community, Men's Health, Women's Health
Receiving a breast cancer diagnosis can be a life-altering moment, one that is often accompanied by a whirlwind of emotions, questions, and uncertainty. Coping with breast cancer is a journey that requires strength, support, and resilience. In this blog, we’ll...
by Comanche County Memorial Hospital | Oct 9, 2023 | Cancer Care, CCMH Community, Men's Health, Women's Health
Breast cancer affects millions of women around the world each year. The good news is that early detection can significantly improve the chances of successful treatment and long-term survival. One crucial tool in the fight against breast cancer is the mammogram. In...
by Comanche County Memorial Hospital | Oct 2, 2023 | Cancer Care, CCMH Community, Men's Health, Women's Health
As the leaves turn a warm shade of red and gold, another color takes center stage in October – pink. This vibrant color not only represents the beauty of the fall season but also the strength, resilience, and unity of those affected by breast cancer. Comanche County...
by Comanche County Memorial Hospital | Sep 25, 2023 | CCMH Community, Community Health, Healthy Living, Men's Health, Women's Health
Sickle cell disease (SCD) is the most common inherited blood disorder in the United States. According to the National Heart, Lung, and Blood Institute (NHLBI), nearly 100,000 Americans and more than 20 million people worldwide are affected by SCD. Until recently,...
by Comanche County Memorial Hospital | Sep 12, 2023 | Cancer Care, Women's Health
[vc_row][vc_column][vc_column_text] A new drug, jointly developed by Arvinas and Pfizer, against breast cancer, ARV-471, has had great success in its clinical trials thus far. The Cancer Centers of Southwest Oklahoma is the first in the US to enroll a patient in...
